Janice Cowden/lbbc.org
Feb 9, 2025, 16:06
Janice Cowden: Dosing and side effects with Trodelvy, Enhertu, Kadcyla and ADCs in clinical trial
Janice Cowden, Former nurse, Cancer patient and Advocate, posted on LinkedIn:
“Help the Patient-Centered Dosing Initiative answer questions about dosing and side effects with Trodelvy, Enhertu, Kadcyla and antibody-drug conjugates (ADCs) in clinical trial. If you live in the US, have been on one of these drugs and have Metastatic Breast Cancer, we need to hear from you. The research survey takes about 20 minutes, and we hope will lead to better understanding and improve future treatment experience. The results from this survey will be posted at following presentation/publication.
E-mail [email protected] for a survey link!
If you have questions about the survey, please reach out to [email protected].”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 2, 2025, 22:37
Sep 2, 2025, 22:03
Sep 2, 2025, 20:50
Sep 2, 2025, 18:53
Sep 2, 2025, 16:54